Einat B. Vitner

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed et al. · Nature Communications · 2020 · 228 citations · Full text

RIPK3 as a potential therapeutic target for Gaucher's disease

Einat B. Vitner, Ran Salomon, Tamar Farfel‐Becker et al. · Nature Medicine · 2014 · 158 citations

Potential Therapeutic Target, Receptor Tyrosine Kinase, Autophagy +5

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Melissa L. Boby, D. Fearon, Matteo P. Ferla et al. · Science · 2023 · 158 citations · Full text

Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease

Einat B. Vitner, Tamar Farfel‐Becker, Raya Eilam et al. · Brain · 2012 · 153 citations · Full text

Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration

Tamar Farfel‐Becker, Einat B. Vitner, Steven L. Kelly et al. · Human Molecular Genetics · 2013 · 152 citations · Full text

Substrate Reduction Therapy, Glucosylceramide Accumulation, Social Sciences +19